Boehringer Ingelheim, Lupin in agreement for type II diabetes
Lupin to market Empagliflozin under the brand name Gibtulio in India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Glenmark appoints Dr Kurt Stoeckli as President and CSO
Dr Stoeckli will oversee Glenmark’s entire research portfolio including biologics and small molecules
CPhI & P-MEC to host ‘India Pharma Week 2016’
This year's expo will see participation from over 100 countries, 1300 exhibitors and 40,000 attendees
Sun Pharma recalls 31,762 bottles of antidepressant drug in US
The tablets were manufactured by Sun Pharma at its Halol plant
Geistlich Pharma forays into India
The company's two globally recognised products Bio-Oss and Bio-Gide will aid in dental regeneration
Warehousing space demand to grow eight per cent annually: Knight Frank
With investment returns of 22-24 per cent per annum, Pune offers the best investment opportunity in India
Warehousing space…
DRL launches lamotrigine orally disintegrating tablets in US
The therapeutic equivalent generic version of Lamictal ODT is available in 25 mg, 50 mg, 100 mg, and 200 mg
MedGenome acquire Illumina Hiseq X Ten platform
The machines are expected to be operational in India and the US by next month
Lupin, MonoSol Rx sign pact for multiple pediatric products
PharmFilm technology to be used for pediatric applications